Form 8-K - Current report:
SEC Accession No. 0001062822-25-000003
Filing Date
2025-01-02
Accepted
2025-01-02 16:04:14
Documents
14
Period of Report
2025-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20250102.htm   iXBRL 8-K 28970
2 EX-10.1 exh101-coianteofferletter0.htm EX-10.1 15598
  Complete submission text file 0001062822-25-000003.txt   172761

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20250102.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20250102_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20250102_pre.xml EX-101.PRE 12504
16 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20250102_htm.xml XML 2738
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 25501978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)